Drug Shortage Report for LOSARTAN HCT

Last updated on 2020-05-08 History
Report ID 84359
Drug Identification Number 02388960
Brand name LOSARTAN HCT
Common or Proper name LOSARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2019-06-12
Actual start date 2019-06-12
Estimated end date Unknown
Actual end date 2020-05-07
Shortage status Resolved
Updated date 2020-05-08
Company comments
Health Canada comments
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-05-08 English Compare
v19 2020-05-07 French Compare
v18 2020-05-07 English Compare
v17 2019-08-05 French Compare
v16 2019-08-05 English Compare
v15 2019-07-26 French Compare
v14 2019-07-26 English Compare
v13 2019-06-28 French Compare
v12 2019-06-28 English Compare
v11 2019-06-17 French Compare
v10 2019-06-17 English Compare
v9 2019-06-13 English Compare
v8 2019-06-12 French Compare
v7 2019-06-12 English Compare
v6 2019-06-10 French Compare
v5 2019-06-10 English Compare
v4 2019-05-31 French Compare
v3 2019-05-31 English Compare
v2 2019-05-17 French Compare
v1 2019-05-17 English Compare